New obesity drug aims to cut side effects with smarter dosing
NCT ID NCT06718998
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 25 times
Summary
This study tested a new medicine called NNC0519-0130 for people with overweight or obesity. Researchers wanted to see if different ways of slowly increasing the dose could reduce side effects. About 134 adults with a BMI between 27 and 45 took part. The study lasted 24 weeks and focused on safety and how well the medicine was tolerated.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Medical University of Graz
Graz, 8010, Austria
Conditions
Explore the condition pages connected to this study.